2012-12-14 08:22:22 - More than 200 biopharmaceutical and clinical trial supply chain leaders in China will attend the China Bio/Pharmaceutical and Clinical Supply Chain Convention (16-17 January 2013, Beijing), to explore how to prepare for the new GSP and evaluate new solutions and practices to meet the requirements.
As drug manufacturing shifts to China, pharmaceutical companies face pressing challenges to develop an efficient cold chain distribution system for biopharmaceutical products and clinical trial supplies in a country which is at the point of becoming the world’s largest biopharmaceutical market.
Massive obstacles in the country include environmental, structural and regulatory factors. To alleviate this problem, China’s Ministry of Health released the new, expanded draft of GSP to clarify drug distribution roles. “The topics at the China Bio/Pharmaceutical and Clinical Supply Chain Convention 2013 are pertinent in addressing supply chain challenges and issues for clinical trials in China”, noted Cheng Dachen, Head of China Sourcing Team, AstraZeneca China.
Bringing together more than 40 distinguished speakers at the convention, the highly anticipated
event is expecting a turnout of more than 200 delegates, with one of the speakers, Linc Chen, Head of Clinical Supply Chain Management China from Bayer Healthcare R&D commenting, “I am pleased to be part of the speaker panel for the China Bio/Pharmaceutical and Clinical Supply Chain Convention 2013 and looking forward to participating in the engaging discussions.”
Confirmed attendees include senior representatives from Beijing Drug Administration and decision makers from companies including Pfizer, GSK, Bayer Healthcare, Sanofi-Aventis, China National Pharmaceutical Group and Beijing Tongrentang, amongst others.
The China Bio/Pharmaceutical and Clinical Supply Chain Convention is the fourth annual event for the biopharmaceutical sector in China, and will feature over 200 senior delegates in attendance, making it the country’s largest gathering of biopharmaceutical and clinical trial supply professionals. The convention is part of Pharma IQ’s global cold chain and clinical trial logistics event series aimed at providing a platform for supply chain, quality assurance, regulatory affairs, packaging and clinical operations professionals to come together an discuss best practice solutions to tackle pertinent issues in China.